Jay S. Schneider, PhD, received his PhD from the State University of New York at Stony Brook and received postdoctoral training at the University of California, Los Angeles. Dr. Schneider leads basic and clinical research efforts on Parkinson’s disease at Thomas Jefferson University. His research focuses on the following areas: (i) understanding the pathophysiology of Parkinson’s disease and developing neuroprotective/neurorestorative therapies for the disease, (ii) development and evaluation of new treatments to alleviate motor symptoms of Parkinson’s disease, (iii) development of anti-dyskinesia therapies, (iv) understanding cognitive dysfunction in Parkinson’s disease and development of new treatments for cognitive dysfunction, and (v) exploration of an epigenetic basis for development of Parkinson’s disease. Dr. Schneider also oversees a number of clinical trials of new therapeutics for Parkinson’s disease.